{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:49:31Z","timestamp":1791334171245,"version":"4.3.1"},"reference-count":96,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1097\/mop.0000000000000061","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T12:30:55Z","timestamp":1392813055000},"page":"180-186","source":"Crossref","is-referenced-by-count":14,"title":["Renal osteodystrophy in children"],"prefix":"10.1097","volume":"26","author":[{"given":"Markus J.","family":"Kemper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"van Husen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-10-20210206","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/j.ajkd.2012.12.010","article-title":"Changes in bone matrix mineralization after growth hormone treatment in children and adolescents with chronic kidney failure treated by dialysis: a paired biopsy study.","volume":"61","author":"Nawrot-Wawrzyniak","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R3-10-20210206","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00467-012-2324-4","article-title":"Bone disease in pediatric chronic kidney disease.","volume":"28","author":"Wesseling-Perry","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R4-10-20210206","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2012.10.008","article-title":"The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complications.","volume":"54","author":"Wesseling-Perry","year":"2013","journal-title":"Bone"},{"key":"R5-10-20210206","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"R6-10-20210206","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1681\/ASN.2011111115","article-title":"Cardiovascular disease in children with chronic kidney disease.","volume":"23","author":"Mitsnefes","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R7-10-20210206","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works.","volume":"18","author":"Liu","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R8-10-20210206","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-10-20210206","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease.","volume":"82","author":"Wolf","year":"2012","journal-title":"Kidney Int"},{"key":"R10-10-20210206","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-030212-183727","article-title":"Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.","volume":"75","author":"Hu","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"R11-10-20210206","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1681\/ASN.2011101006","article-title":"Calcium deficiency reduces circulating levels of FGF23.","volume":"23","author":"Rodriguez-Ortiz","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R12-10-20210206","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wntbeta-catenin signaling is an early event in the progression of renal osteodystrophy.","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J Bone Miner Res"},{"key":"R13-10-20210206","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","article-title":"Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.","volume":"90","author":"Thambiah","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"R14-10-20210206","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","article-title":"The relation between renal function and serum sclerostin in adult patients with CKD.","volume":"8","author":"Pelletier","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R15-10-20210206","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrneph.2013.111","article-title":"Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism.","volume":"9","author":"Kuro","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"R16-10-20210206","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2009-1576","article-title":"The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.","volume":"95","author":"Bacchetta","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-10-20210206","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ki.2010.107","article-title":"Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease.","volume":"78","author":"van Husen","year":"2010","journal-title":"Kidney Int"},{"key":"R18-10-20210206","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1093\/ndt\/gfs109","article-title":"Investigating FGF-23 concentrations and its relationship with declining renal function in paediatric patients with predialysis CKD stages 3-5.","volume":"27","author":"Sinha","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R19-10-20210206","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1681\/ASN.2009040427","article-title":"FGF23 fails to inhibit uremic parathyroid glands.","volume":"21","author":"Canalejo","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R20-10-20210206","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ki.2009.414","article-title":"Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.","volume":"77","author":"Komaba","year":"2010","journal-title":"Kidney Int"},{"key":"R21-10-20210206","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.jrn.2011.12.009","article-title":"Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.","volume":"23","author":"Houston","year":"2013","journal-title":"J Ren Nutr"},{"key":"R22-10-20210206","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy.","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"R23-10-20210206","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23.","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"R24-10-20210206","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease.","volume":"22","author":"Hu","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R25-10-20210206","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000346778","article-title":"Klotho and chronic kidney disease.","volume":"180","author":"Hu","year":"2013","journal-title":"Contrib Nephrol"},{"key":"R26-10-20210206","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/03008207.2012.753879","article-title":"Fibroblast growth factor 23 and Klotho are present in the growth plate.","volume":"54","author":"Raimann","year":"2013","journal-title":"Connect Tissue Res"},{"key":"R27-10-20210206","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1681\/ASN.2012010048","article-title":"Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism.","volume":"23","author":"Olauson","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R28-10-20210206","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00424-013-1226-z","article-title":"Fibroblast growth factor 23 enhances renal klotho abundance.","volume":"465","author":"Takenaka","year":"2013","journal-title":"Pflugers Arch"},{"key":"R30-10-20210206","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ki.2012.370","article-title":"Circulating Klotho levels: clinical relevance and relationship with tissue Klotho expression.","volume":"83","author":"Drueke","year":"2013","journal-title":"Kidney Int"},{"key":"R31-10-20210206","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbrc.2010.06.110","article-title":"Establishment of sandwich ELISA for soluble alpha-Klotho measurement: age-dependent change of soluble alpha-Klotho levels in healthy subjects.","volume":"398","author":"Yamazaki","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"R32-10-20210206","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ndt\/gfs460","article-title":"Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.","volume":"28","author":"Pavik","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R33-10-20210206","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ki.2012.288","article-title":"Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease.","volume":"83","author":"Seiler","year":"2013","journal-title":"Kidney Int"},{"key":"R34-10-20210206","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ndt\/gfs411","article-title":"Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.","volume":"28","author":"Wan","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R35-10-20210206","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ki.2013.271","article-title":"Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.","volume":"85","author":"Fang","year":"2014","journal-title":"Kidney Int"},{"key":"R36-10-20210206","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/ki.2013.254","article-title":"Recent advances in the noninvasive diagnosis of renal osteodystrophy.","volume":"84","author":"Moorthi","year":"2013","journal-title":"Kidney Int"},{"key":"R37-10-20210206","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MNH.0b013e32835dda01","article-title":"Bone biopsy in renal osteodystrophy: continued insights into a complex disease.","volume":"22","author":"Christov","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R38-10-20210206","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2215\/CJN.05940611","article-title":"Early skeletal and biochemical alterations in pediatric chronic kidney disease.","volume":"7","author":"Wesseling-Perry","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R39-10-20210206","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2215\/CJN.12871211","article-title":"Bone mineral density and fracture risk in older individuals with CKD.","volume":"7","author":"Yenchek","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R40-10-20210206","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1007\/s00198-012-1908-y","article-title":"Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease.","volume":"23","author":"Jamal","year":"2012","journal-title":"Osteoporos Int"},{"key":"R41-10-20210206","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients: a single-center cohort study.","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R42-10-20210206","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/ki.2012.166","article-title":"Bone microarchitecture is more severely affected in patients on hemodialysis than in those receiving peritoneal dialysis.","volume":"82","author":"Pelletier","year":"2012","journal-title":"Kidney Int"},{"key":"R43-10-20210206","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.2012.347","article-title":"Changes in bone structure and the muscle-bone unit in children with chronic kidney disease.","volume":"83","author":"Tsampalieros","year":"2013","journal-title":"Kidney Int"},{"key":"R44-10-20210206","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00467-012-2116-x","article-title":"Assessment of dual-energy X-ray absorptiometry measures of bone health in pediatric chronic kidney disease.","volume":"27","author":"Griffin","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R45-10-20210206","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jc.2012-4188","article-title":"Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease.","volume":"98","author":"Denburg","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-10-20210206","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00467-010-1745-1","article-title":"Bone assessment in children with chronic kidney disease: data from two new bone imaging techniques in a single-center pilot study.","volume":"26","author":"Bacchetta","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R47-10-20210206","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1515\/cclm-2012-0485","article-title":"Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy.","volume":"51","author":"Beko","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"R48-10-20210206","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.clinbiochem.2013.06.023","article-title":"The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in predialysis chronic kidney disease (CKD).","volume":"46","author":"OFlaherty","year":"2013","journal-title":"Clin Biochem"},{"key":"R49-10-20210206","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000350149","article-title":"Modeling of oxidized PTH (oxPTH) and nonoxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipients.","volume":"37","author":"Hocher","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"R50-10-20210206","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/j.ajkd.2013.02.366","article-title":"Bone alkaline phosphatase in CKD-mineral bone disorder.","volume":"62","author":"Sardiwal","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R51-10-20210206","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ki.2012.77","article-title":"Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients.","volume":"82","author":"Sardiwal","year":"2012","journal-title":"Kidney Int"},{"key":"R52-10-20210206","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"R53-10-20210206","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ki.2012.19","article-title":"Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients.","volume":"82","author":"Bhan","year":"2012","journal-title":"Kidney Int"},{"key":"R54-10-20210206","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00467-012-2143-7","article-title":"Vitamin D status in children with chronic kidney disease.","volume":"27","author":"Stein","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R55-10-20210206","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/ndt\/gfr382","article-title":"Serum fetuin-A and vitamin D in children with mild-to-severe chronic kidney disease: a cross-sectional study.","volume":"27","author":"Schaible","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R56-10-20210206","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3747\/pdi.2011.00246","article-title":"Prevalence of 25(OH) vitamin D insufficiency and deficiency in pediatric patients on chronic dialysis.","volume":"33","author":"Cho","year":"2013","journal-title":"Perit Dial Int"},{"key":"R57-10-20210206","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00467-012-2347-x","article-title":"Phosphate is a vascular toxin.","volume":"28","author":"Shroff","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R58-10-20210206","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00467-012-2381-8","article-title":"Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children.","volume":"28","author":"Wesseling-Perry","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R59-10-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000354711","article-title":"Management of hyperphosphataemia in chronic kidney disease: summary of National Institute for Health and Clinical Excellence (NICE) Guideline.","volume":"124","author":"Dasgupta","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"R60-10-20210206","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/j.ajkd.2013.04.013","article-title":"Gastrointestinal phosphate handling in CKD and its association with cardiovascular disease.","volume":"62","author":"Weinman","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R61-10-20210206","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2215\/CJN.07640711","article-title":"Acute effects of very-low-protein diet on FGF23 levels: a randomized study.","volume":"7","author":"Di Iorio","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R62-10-20210206","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2215\/CJN.09250912","article-title":"Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.","volume":"8","author":"Isakova","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R63-10-20210206","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/ndt\/gfs333","article-title":"High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease.","volume":"28","author":"Lau","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R64-10-20210206","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/ndt\/gfs405","article-title":"Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial.","volume":"28","author":"Sigrist","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R65-10-20210206","first-page":"476","article-title":"Dietary intervention focused on phosphate intake in hemodialysis patients with hyperphosphoremia.","volume":"77","author":"Lou","year":"2012","journal-title":"Clin Nephrol"},{"key":"R66-10-20210206","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease.","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"key":"R67-10-20210206","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD.","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R68-10-20210206","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus noncalcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.","volume":"382","author":"Jamal","year":"2013","journal-title":"Lancet"},{"key":"R69-10-20210206","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.ajkd.2013.03.023","article-title":"Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial.","volume":"62","author":"Di Iorio","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R70-10-20210206","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/ndt\/gft203","article-title":"A comparison of calcium acetatemagnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study.","volume":"28","author":"Covic","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R71-10-20210206","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000351811","article-title":"Effect of a noncalcium-based phosphate binder on fibroblast growth factor 23 in chronic kidney disease.","volume":"123","author":"Spatz","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"R72-10-20210206","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3109\/0886022X.2013.828365","article-title":"Effects and safety of lanthanum carbonate in end stage renal disease patients with hyperphosphatemia: a meta-analysis: system review of lanthanum carbonate.","volume":"35","author":"Guo","year":"2013","journal-title":"Ren Fail"},{"key":"R73-10-20210206","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2369-14-29","article-title":"Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China.","volume":"14","author":"Xu","year":"2013","journal-title":"BMC Nephrol"},{"key":"R74-10-20210206","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1471-2369-14-226","article-title":"Efficacy and safety of lanthanum carbonate on chronic kidney disease: mineral and bone disorder in dialysis patients: a systematic review.","volume":"14","author":"Zhang","year":"2013","journal-title":"BMC Nephrol"},{"key":"R75-10-20210206","doi-asserted-by":"crossref","first-page":"c25","DOI":"10.1159\/000341922","article-title":"The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients.","volume":"121","author":"Sinsakul","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"R76-10-20210206","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1053\/j.ajkd.2012.11.041","article-title":"Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.","volume":"61","author":"Dwyer","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R79-10-20210206","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4161\/derm.20014","article-title":"Vitamin D supplementation in predialysis chronic kidney disease: a systematic review.","volume":"4","author":"Alvarez","year":"2012","journal-title":"Dermatoendocrinol"},{"key":"R80-10-20210206","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2369-14-199","article-title":"Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies.","volume":"14","author":"Zheng","year":"2013","journal-title":"BMC Nephrol"},{"key":"R81-10-20210206","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1172\/JCI45890","article-title":"Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization.","volume":"122","author":"Lieben","year":"2012","journal-title":"J Clin Invest"},{"key":"R82-10-20210206","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.2012.12505","article-title":"Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial.","volume":"308","author":"Murdoch","year":"2012","journal-title":"J Am Med Assoc"},{"key":"R83-10-20210206","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3945\/ajcn.112.040642","article-title":"High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.","volume":"96","author":"Alvarez","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"R84-10-20210206","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2215\/CJN.04760511","article-title":"Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial.","volume":"7","author":"Shroff","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R85-10-20210206","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.2013030203","article-title":"Active vitamin d treatment for reduction of residual proteinuria: a systematic review.","volume":"24","author":"de Borst","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R87-10-20210206","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD: The OPERA Trial.","volume":"25","author":"Wang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R88-10-20210206","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1093\/ndt\/gft227","article-title":"Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study.","volume":"28","author":"Coyne","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R89-10-20210206","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00246-012-0489-z","article-title":"Vitamin D deficiency is associated with increased left ventricular mass and diastolic dysfunction in children with chronic kidney disease.","volume":"34","author":"Patange","year":"2013","journal-title":"Pediatr Cardiol"},{"key":"R90-10-20210206","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00246-011-0101-y","article-title":"Vitamin D deficiency and arterial wall stiffness in children with chronic kidney disease.","volume":"33","author":"Patange","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"R91-10-20210206","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ahj.2012.09.018","article-title":"Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease.","volume":"164","author":"Tamez","year":"2012","journal-title":"Am Heart J"},{"key":"R92-10-20210206","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1093\/ndt\/gft268","article-title":"Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis.","volume":"28","author":"Panizo","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R93-10-20210206","doi-asserted-by":"crossref","first-page":"e1001436","DOI":"10.1371\/journal.pmed.1001436","article-title":"Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials.","volume":"10","author":"Palmer","year":"2013","journal-title":"PLoS Med"},{"key":"R94-10-20210206","first-page":"651","article-title":"What have we learned about chronic kidney disease-mineral bone disorder from the EVOLVE and PRIMO trials Curr Opin Nephrol H","volume":"22","author":"Moe","year":"2013","journal-title":"ypertens"},{"key":"R95-10-20210206","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1210\/jc.2013-2975","article-title":"The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: The EVOLVE Trial.","volume":"98","author":"Parfrey","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R96-10-20210206","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1515\/jpem-2012-0214","article-title":"Short- and middle-term continuous use of cinacalcet in children on peritoneal dialysis.","volume":"26","author":"Dotis","year":"2013","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R97-10-20210206","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/ki.2012.253","article-title":"Bisphosphonate safety and efficacy in chronic kidney disease.","volume":"82","author":"Ott","year":"2012","journal-title":"Kidney Int"},{"key":"R98-10-20210206","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.ajkd.2011.11.037","article-title":"Bisphosphonate therapy, death, and cardiovascular events among female patients with CKD: a retrospective cohort study.","volume":"59","author":"Hartle","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R99-10-20210206","first-page":"2111","article-title":"Can bisphosphonates play a role in the treatment of children with chronic kidney disease Pediatr N","volume":"26","author":"Haffner","year":"2011","journal-title":"ephrol"},{"key":"R100-10-20210206","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.2215\/CJN.02640310","article-title":"Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the trade-off hypothesis.","volume":"5","author":"Gutierrez","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R101-10-20210206","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/ndt\/gfs557","article-title":"FGF23 antagonism: the thin line between adaptation and maladaptation in chronic kidney disease.","volume":"28","author":"Ketteler","year":"2013","journal-title":"Nephrol Dial Transplant"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:28:19Z","timestamp":1620962899000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201404000-00010"}},"subtitle":["pathogenesis, diagnosis and treatment"],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000061","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}